메뉴 건너뛰기




Volumn 8, Issue 10, 2011, Pages 2810-2815

Does the female sexual distress scale-revised cover the feelings of women with HSDD?

Author keywords

Female sexual distress Scale Revised; Female sexual dysfunction; Hypoactive sexual desire disorder; Low sexual desire

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COMPREHENSION; CONTENT VALIDITY; EMOTIONAL STRESS; FEMALE; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; INTERVIEW; PRIORITY JOURNAL; RATING SCALE; REVISED FEMALE SEXUAL DISTRESS SCALE; UNITED STATES; VALIDATION STUDY;

EID: 80053565980     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02385.x     Document Type: Article
Times cited : (34)

References (10)
  • 1
    • 0003893456 scopus 로고    scopus 로고
    • American Psychiatric Association. 4th edition. Text revision. Washington, DC: American Psychiatric Press.
    • American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Text revision. Washington, DC: American Psychiatric Press; 2000.
    • (2000) DSM-IV: Diagnostic and Statistical Manual of Mental Disorders
  • 3
    • 74049120718 scopus 로고    scopus 로고
    • Standards for clinical trials in sexual dysfunction in women: Research designs and outcomes assessment
    • Clayton AH, Dennerstein L, Fisher WA, Kingsberg SA, Perelman MA, Pyke RE. Standards for clinical trials in sexual dysfunction in women: Research designs and outcomes assessment. J Sex Med 2010;7:541-60.
    • (2010) J Sex Med , vol.7 , pp. 541-560
    • Clayton, A.H.1    Dennerstein, L.2    Fisher, W.A.3    Kingsberg, S.A.4    Perelman, M.A.5    Pyke, R.E.6
  • 4
    • 0035989571 scopus 로고    scopus 로고
    • The Female Sexual Distress Scale (FSDS): Initial validation of a standardized scale for assessment of sexually related personal distress in women
    • DeRogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. The Female Sexual Distress Scale (FSDS): Initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther 2002;28:317-30.
    • (2002) J Sex Marital Ther , vol.28 , pp. 317-330
    • DeRogatis, L.R.1    Rosen, R.2    Leiblum, S.3    Burnett, A.4    Heiman, J.5
  • 5
    • 38649140661 scopus 로고    scopus 로고
    • Validation of the female sexual distress scale - revised for assessing distress in women with hypoactive sexual desire disorder
    • DeRogatis L, Clayton A, Lewis D'Agostino D, Wunderlich G, Fu Y. Validation of the female sexual distress scale - revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med 2008;5:357-64.
    • (2008) J Sex Med , vol.5 , pp. 357-364
    • DeRogatis, L.1    Clayton, A.2    Lewis D'Agostino, D.3    Wunderlich, G.4    Fu, Y.5
  • 6
    • 80053561968 scopus 로고    scopus 로고
    • Food and Drug Administration. Guidance for industry. Patient-reported outcome measures: Use in medical product development to support labeling claims. Available at: (accessed May 6, 2008).
    • Food and Drug Administration. Guidance for industry. Patient-reported outcome measures: Use in medical product development to support labeling claims. 2006. Available at: (accessed May 6, 2008).
    • (2006)
  • 7
    • 61549090011 scopus 로고    scopus 로고
    • Validation of the Decreased Sexual Desire Screener (DSDS): A brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD)
    • Clayton AH, Goldfischer ER, Goldstein I, DeRogatis L, Lewis D'Agostino DJ, Pyke R. Validation of the Decreased Sexual Desire Screener (DSDS): A brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). J Sex Med 2009;6:730-8.
    • (2009) J Sex Med , vol.6 , pp. 730-738
    • Clayton, A.H.1    Goldfischer, E.R.2    Goldstein, I.3    DeRogatis, L.4    Lewis D'Agostino, D.J.5    Pyke, R.6
  • 8
    • 80053575996 scopus 로고    scopus 로고
    • Food and Drug Administration. Guidance for industry. Female sexual dysfunction: Clinical development of drug products for treatment. ). Draft guidance. Available at: (accessed May 6, 2008).
    • Food and Drug Administration. Guidance for industry. Female sexual dysfunction: Clinical development of drug products for treatment. 2000). Draft guidance. Available at: (accessed May 6, 2008).
    • (2000)
  • 9
    • 12744263248 scopus 로고    scopus 로고
    • Outcome measurement in female sexual dysfunction clinical trials: Review and recommendations
    • Althof SE, Rosen RC, DeRogatis L, Corty E, Quirk F, Symonds T. Outcome measurement in female sexual dysfunction clinical trials: Review and recommendations. J Sex Marital Ther 2005;31:153-66.
    • (2005) J Sex Marital Ther , vol.31 , pp. 153-166
    • Althof, S.E.1    Rosen, R.C.2    DeRogatis, L.3    Corty, E.4    Quirk, F.5    Symonds, T.6
  • 10
    • 34247619494 scopus 로고    scopus 로고
    • Women's views of their sexual difficulties: Agreement and disagreement with clinical diagnoses
    • King M, Holt V, Nazareth I. Women's views of their sexual difficulties: Agreement and disagreement with clinical diagnoses. Arch Sex Behav 2007;36:281-8.
    • (2007) Arch Sex Behav , vol.36 , pp. 281-288
    • King, M.1    Holt, V.2    Nazareth, I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.